166 related articles for article (PubMed ID: 30744988)
1. Streptococcal toxic shock syndrome caused by β-hemolytic streptococci: Clinical features and cytokine and chemokine analyses of 15 cases.
Yoshizawa S; Matsumura T; Ikebe T; Ichibayashi R; Fukui Y; Satoh T; Tsubota T; Honda M; Ishii Y; Tateda K; Ato M
J Infect Chemother; 2019 May; 25(5):355-361. PubMed ID: 30744988
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome.
Ikebe T; Okuno R; Sasaki M; Kanda Y; Otsuka H; Kawahara R; Ohya H; Suzuki M; Uchida K; Nihonmatsu H; Ohnishi M;
J Infect Chemother; 2018 Feb; 24(2):117-122. PubMed ID: 29107650
[TBL] [Abstract][Full Text] [Related]
3. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
Baxter M; Morgan M
Emerg Infect Dis; 2017 Jan; 23(1):127-129. PubMed ID: 27983491
[TBL] [Abstract][Full Text] [Related]
4. A case of streptococcal toxic shock syndrome due to Group G streptococci identified as Streptococcus dysgalactiae subsp. equisimilis.
Nei T; Akutsu K; Shima A; Tsuboi I; Suzuki H; Yamamoto T; Tanaka K; Shinoyama A; Kojima Y; Washio Y; Okawa S; Sonobe K; Norose Y; Saito R
J Infect Chemother; 2012 Dec; 18(6):919-24. PubMed ID: 22327489
[TBL] [Abstract][Full Text] [Related]
5. [Beta-hemolytic streptococcal bacteremia in adults].
Rantala S
Duodecim; 2013; 129(14):1477-84. PubMed ID: 23961606
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
[TBL] [Abstract][Full Text] [Related]
7. [Toxic shock-like syndrome caused by streptococci].
van Dissel JT; Kullberg BJ; van der Meer JW
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1452-5. PubMed ID: 10443259
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology of Streptococcus pyogenes invasive diseases in France (2007-2011)].
Plainvert C; Loubinoux J; Bidet P; Doloy A; Touak G; Dmytruk N; Collobert G; Bingen E; Bouvet A; Fouet A; Poyart C
Arch Pediatr; 2014 Nov; 21 Suppl 2():S62-8. PubMed ID: 25456682
[TBL] [Abstract][Full Text] [Related]
9. Invasive group A streptococcal infections in adults, France (2006-2010).
Plainvert C; Doloy A; Loubinoux J; Lepoutre A; Collobert G; Touak G; Trieu-Cuot P; Bouvet A; Poyart C;
Clin Microbiol Infect; 2012 Jul; 18(7):702-10. PubMed ID: 21883669
[TBL] [Abstract][Full Text] [Related]
10. Systemic cytokine response in moribund mice of streptococcal toxic shock syndrome model.
Saito M; Kajiwara H; Iida K; Hoshina T; Kusuhara K; Hara T; Yoshida S
Microb Pathog; 2011 Feb; 50(2):109-13. PubMed ID: 21146602
[TBL] [Abstract][Full Text] [Related]
11. ICU Management of Invasive β-Hemolytic Streptococcal Infections.
Babiker A; Kadri SS
Infect Dis Clin North Am; 2022 Dec; 36(4):861-887. PubMed ID: 36328640
[TBL] [Abstract][Full Text] [Related]
12. MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome.
Emgård J; Bergsten H; McCormick JK; Barrantes I; Skrede S; Sandberg JK; Norrby-Teglund A
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25923-25931. PubMed ID: 31772015
[TBL] [Abstract][Full Text] [Related]
13. Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections.
Norrby-Teglund A; Pauksens K; Norgren M; Holm SE
Scand J Infect Dis; 1995; 27(2):125-30. PubMed ID: 7660074
[TBL] [Abstract][Full Text] [Related]
14. [Streptococcal toxic shock-like syndrome caused by Streptococcus dysgalactiae subsp. equisimilis in a patient with acute myeloid leukemia at diagnosis].
Mori M; Kitagawa T; Sasaki Y; Onaka T; Yonezawa A; Imada K
Rinsho Ketsueki; 2013 Feb; 54(2):219-23. PubMed ID: 23470831
[TBL] [Abstract][Full Text] [Related]
15. Streptococcal toxic-shock syndrome due to Streptococcus dysgalactiae subspecies equisimilis in breast cancer-related lymphedema: a case report.
Sumazaki M; Saito F; Ogata H; Yoshida M; Kubota Y; Magoshi S; Kaneko H
J Med Case Rep; 2017 Jul; 11(1):191. PubMed ID: 28705211
[TBL] [Abstract][Full Text] [Related]
16. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates.
Norrby-Teglund A; Lustig R; Kotb M
Infect Immun; 1997 Dec; 65(12):5209-15. PubMed ID: 9393817
[TBL] [Abstract][Full Text] [Related]
17. Streptococcal toxic shock syndrome: report of two cases.
Kaneita Y; Takata C; Itobayashi E; Miyauchi Y; Asada M; Irabu N; Yoshida S
Intern Med; 1995 Jul; 34(7):643-5. PubMed ID: 7496075
[TBL] [Abstract][Full Text] [Related]
18. Infections due to group A streptococcus: new concepts and potential treatment strategies.
Norrby SR; Norrby-Teglund A
Ann Acad Med Singap; 1997 Sep; 26(5):691-3. PubMed ID: 9494680
[TBL] [Abstract][Full Text] [Related]
19. Streptococcal toxic shock syndrome in dogs.
Miller CW; Prescott JF; Mathews KA; Betschel SD; Yager JA; Guru V; DeWinter L; Low DE
J Am Vet Med Assoc; 1996 Oct; 209(8):1421-6. PubMed ID: 8870738
[TBL] [Abstract][Full Text] [Related]
20. Group B Streptococcal Toxic Shock Syndrome and covR/S Mutations Revisited.
Sendi P; El Hay MA; Brandt CM; Spellerberg B
Emerg Infect Dis; 2017 Jan; 23(1):150-152. PubMed ID: 27983484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
